Efgartigimod with recombinant human hyaluronidase PH20 for treating chronic inflammatory demyelinating polyneuropathy [ID6409]
In development
Reference number: GID-TA11508
Expected publication date:
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin during early August 2025 when we will write to you about how you can get involved.